Chinese Medicine Formula “Jian-Pi-Zhi-Dong Decoction” Attenuates Tourette Syndrome via Downregulating the Expression of Dopamine Transporter in Mice

• Published in: Evidence-based complementary and alternative medicine Vol. 2013; no. 2013; pp. 1 - 9
• Main Authors: Zhang, Jin-ming, Li, Wei, Liu, Xiao-fang, Wang, Su-mei, Wang, Dao-han
• Format: Journal Article
• Language: English
• Published: Cairo, Egypt Hindawi Puplishing Corporation 01.01.2013; Hindawi Publishing Corporation; Hindawi Limited
• Subjects: Attention deficit hyperactivity disorder; Behavior; Child & adolescent psychiatry; Chinese medicine; Dopamine; Dopamine transporter; Gilles de la Tourette syndrome; Herbal medicine; Immunohistochemistry; Methamphetamine; Mice; mRNA; Neostriatum; Obsessive compulsive disorder; Pharmaceuticals; Rodents; Stereotyped behavior; Tourette syndrome; Traditional Chinese medicine; Beijing China; United States > US; China
• ISSN: 1741-427X; 1741-4288
• DOI: 10.1155/2013/385685

Jian-Pi-Zhi-Dong Decoction (JPZDD) is dedicated to the treatment for Tourette syndrome (TS) with the guidance of the theories of Traditional Chinese Medicine (TCM). This study aims to investigate the expression of dopamine transporter (DAT) in the striatum and stereotyped behavior of TS mice model by intervention of JPZDD. Mice were induced by 3,3′-iminodipropionitrile (IDPN, 350 mg kg−1 day−1, i.p.) for 7 days and divided into 4 groups (n=20, each): control and IDPN groups were gavaged with saline and the remaining 2 groups with Tiapride (Tia, 50 mg kg−1 day−1) and JPZDD (20 g kg−1 day−1), respectively. The results showed that the scores of stereotyped behavior in IDPN+JPZDD group were significantly reduced. A noticeably increased 11C-β-CFT binding at bilateral striatum was observed after administration of JPZDD versus that of IDPN or Tia. Immunohistochemistry and in situ hybridization studies manifested higher levels of DAT protein and mRNA in IDPN+JPZDD group. These findings not only demonstrated that JPZDD could effectively inhibit the abnormal behaviors of TS mice model, but also increase the level of DAT in striatum. Therefore, JPZDD could be one of potential treatments of patients with TS.